These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13866013)

  • 1. Hyperlipoproteinemia in nephrosis.
    BAXTER JH
    Arch Intern Med; 1962 Jun; 109():742-57. PubMed ID: 13866013
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in serum lipoproteins in kidney diseases].
    Mordasini R; Riesen W
    Schweiz Med Wochenschr; 1982 Sep; 112(39):1335-40. PubMed ID: 6755693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein profile in childhood nephrotic syndrome: correlation with clinical severity.
    Yap HK; Yip WC; Tay JS; Ho TF; Sothy P
    J Singapore Paediatr Soc; 1988; 30(1-2):56-60. PubMed ID: 3210666
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in serum lipoproteins in kidney diseases. Clinical and pathogenetic aspects].
    Walther A; Mordasini R; Riesen W
    Dtsch Med Wochenschr; 1983 Mar; 108(10):385-7. PubMed ID: 6825580
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in serum lipoproteins in kidney diseases. Therapeutic possibilities].
    Walther A; Mordasini R; Riesen W
    Dtsch Med Wochenschr; 1983 Mar; 108(10):388. PubMed ID: 6337805
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood lipoproteins in nephrotic syndromes].
    PATELSKI J; SZERESZEWSKA H; CHODERA L
    Pol Arch Med Wewn; 1956; 26(10):1515-28. PubMed ID: 13408128
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultracentrifugal analysis of serum lipoproteins in nephrotic syndrome of rats.
    LEWIS LA; HEYMANN W
    Proc Soc Exp Biol Med; 1954; 86(4):766-7. PubMed ID: 13204349
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of infusions of serum albumin on serum lipids and lipoproteins in nephrosis.
    BAXTER JH; GOODMAN HC; ALLEN JC
    J Clin Invest; 1961 Mar; 40(3):490-8. PubMed ID: 13688076
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperlipoproteinemia as a factor in the progression of glomerulonephritis with nephrotic syndrome].
    Smirnov AV; Sazonets GI; Rakitianskaia IA; Travkina ES
    Ter Arkh; 1992; 64(11):45-8. PubMed ID: 1293843
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clearing factor and the inhibiting factor during lipoid nephrosis].
    LARCAN A; WOLFF J; WOLFF R
    J Urol Nephrol (Paris); 1961 Jun; 67():425-32. PubMed ID: 14462392
    [No Abstract]   [Full Text] [Related]  

  • 11. The nephrotic syndrome and ischaemic heart disease.
    Mallick NP; Short CD
    Nephron; 1981; 27(2):54-7. PubMed ID: 7266702
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E phenotype and hyperlipoproteinemia in nephrotic syndrome.
    Lerique B; Moulin B; Delpéro C; Purgus R; Olmer M; Boyer J
    Clin Chem; 1994 May; 40(5):849-50. PubMed ID: 8174269
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperlipoproteinemia in the nephrotic syndrome].
    Yasugi T; Shimizu T; Iijima M; Tomita M; Harada M
    Saishin Igaku; 1972 Mar; 27(3):504-9. PubMed ID: 5021394
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J; Bar-On H; Shafrir E
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the metabolism of plasma proteins in the nephrotic syndrome. II. The lipoproteins.
    GITLIN D; CORNWELL DG; NAKASATO D; ONCLEY JL; HUGHES WL; JANEWAY CA
    J Clin Invest; 1958 Feb; 37(2):172-84. PubMed ID: 13513748
    [No Abstract]   [Full Text] [Related]  

  • 17. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.
    Joven J; Simó JM; Vilella E; Camps J; Espinel E; Villabona C
    Clin Chem; 1995 Jun; 41(6 Pt 1):908-13. PubMed ID: 7768011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of hyperlipoproteinemia in human nephrotic syndrome: influence of renal failure and diabetes mellitus.
    Joven J; Villabona C; Vilella E
    Nephron; 1993; 64(4):565-9. PubMed ID: 8366982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of hyperlipidemia in the nephrotic syndrome.
    Attman PO; Alaupovic P
    Am J Nephrol; 1990; 10 Suppl 1():69-75. PubMed ID: 2256478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electrophoretic study of serum lipoproteins. I. Study of serum lipoproteins in nephrotic syndrome].
    Taskovska D; Kotevska P; Markovik O; Tasevska S; Radenkova M
    God Zb Med Fak Skopje; 1969; 15():267-77. PubMed ID: 5199996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.